Colorectal cancer (CG131)
Fast, easy summary view of NICE guidance on 'colorectal cancer'
Specific, concise statements that act as markers of high-quality, cost-effective patient care
This clinical guideline updates and replaces NICE technology appraisal 93 (TA93). It offers evidence-based advice on the diagnosis and management of colorectal cancer.
In colorectal cancer, cells in the colon or in the rectum start to grow in an uncontrolled way, forming a lump called the primary cancer or primary tumour. Like other cancers, colorectal cancer starts in a small area but can spread to other parts of the body to form metastatic tumours.
The term colorectal cancer covers cancers in both the colon (colon cancer) and the rectum (rectal cancer).
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
Visit the NICE Pathway: colorectal cancer
- None found
This page was last updated: 08 May 2013
- Web format
- NICE Guideline (PDF)
- Full Guideline (PDF)
- CG131 Canser y colon a'r rhefr: deall canllawiau NICE (fformat MS Word)
Information for the public
Implementation tools and resources
- Baseline assessment tool
- Clinical audit tool
- Clinical case scenarios
- Costing report
- Costing template
- Electronic audit tool
- Slide set
- Case study - Implementing early rectal cancer multidisciplinary teams in secondary care
See this guidance in practice
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guideline, contains the recommendations for health professionals and NHS bodies.
The published full clinical guideline for specialists with background, evidence, recommendations and methods used.